Drug intelligence / Profile preview

Citra-Lock

Development stage
Unknown
Lead developer
Dirinco
Modality
Small Molecules
Administration
Intracatheter
01

Overview

Citra-Lock is a concentrated trisodium citrate solution used as a catheter lock solution for patients undergoing chronic hemodialysis. It is designed to be instilled into the lumens of central venous catheters between dialysis sessions to maintain patency and reduce the risk of infection. Citra-Lock works via a dual mechanism: it acts as a potent anticoagulant by chelating ionized calcium, which is a critical cofactor in the coagulation cascade, and it provides antimicrobial properties through its hypertonicity and alkaline pH, which create an environment inhospitable to bacterial growth. Compared to traditional heparin locks, Citra-Lock is associated with a lower risk of systemic bleeding and heparin-induced thrombocytopenia (HIT), while maintaining similar or superior efficacy in preventing catheter-related bloodstream infections (CRBSI) and thrombotic occlusions.

Brand names
Citra-LockCitralock
Other names
Trisodium citrate 46.7%Trisodium citrate 30%Trisodium citrate 4%Concentrated citrate lock

Beyond the preview

Go deeper on Citra-Lock.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Citra-Lock.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call